Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.22.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
REVENUES $ 3,081 $ 3,027 $ 4,949 $ 4,573
COST OF REVENUES 1,159 1,288 2,445 2,106
GROSS PROFIT 1,922 1,739 2,504 2,467
OPERATING EXPENSES:        
Research and development expenses, net 676 646 1,326 1,266
Sales and marketing expenses, net 837 538 1,567 949
General and administrative expenses, net 1,067 329 1,702 651
TOTAL OPERATING EXPENSES 2,580 1,513 4,595 2,866
OPERATING INCOME (LOSS) (658) 226 (2,091) (399)
Financial expenses, net (996) (259) (4,202) (313)
NET COMPREHENSIVE LOSS FOR THE PERIOD $ (1,654) $ (33) $ (6,293) $ (712)
Net loss per share attributable to common shareholders – basic and diluted (in Dollars per share) $ (0.17) $ (0.02) $ (1.09) $ (0.35)
Weighted average number of common stock used in computing net loss per share – basic and diluted (in Shares) 9,522,719 2,047,641 5,787,503 2,047,641